NSE filing, NSE: NACLIND. Summary written from the filing by ALFA Finder's alert engine.
NACL Industries Ltd: key numbers
- Share price
- ₹111.88
- Market cap
- ₹2,621 Cr
- Revenue (annual)
- ₹1,584 Cr
- Net profit (annual)
- ₹4.57 Cr
- P/E (TTM)
- 211.9×Sector 34.1×
- Promoter holding
- 53.69%+0.00% QoQ
- FII holding
- 0.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NACL Industries Ltd
All →NACL Industries Annual General Meeting
NACL Industries is seeking shareholder approval via postal ballot for a material related party transaction involving a Letter of Comfort for its subsidiary.
- Value
- ₹55.00 Cr
- Execution
- 3 years
NACL Industries Annual General Meeting
NACL Industries Limited issued a Postal Ballot Notice seeking member approval for a Material Related Party Transaction with Coromandel International Limited.
NACL Industries Other Announcement
NACL Industries Limited filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
NACL Industries Merger & Restructuring
NACL Industries Limited has executed a Share Purchase Agreement for the divestment of its equity stake in Nasense Labs Private Limited. This follows prior board approval for the sale.
NACL Industries Q1 FY27 Results: Net Profit ₹20.8 Cr, Up 60.0% YoY
NACL Industries Ltd reported net profit of ₹20.8 Cr (+60.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹20.8 Cr · +60.0% YoY
NACL Industries Annual General Meeting
NACL Industries Limited conducted its 39th Annual General Meeting on July 22, 2026. Shareholders adopted financial statements and approved the discussed agenda items.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date